Ben practices corporate and commercial law with a focus on the health and life sciences sectors.
Ben maintains a corporate and commercial practice that includes advising on a broad range of matters including mergers and acquisitions, corporate governance, and commercial agreements. He has particular experience in the charities and not-for-profit spaces. Ben is uniquely positioned to advise companies on potential litigation risk given his previous experience as a litigator at BLG.
Much of Ben’s regulatory and life sciences practice involves advising clients in the medical device, pharmaceutical, and consumer product industries as to compliance with applicable regulatory frameworks, including those pertaining to advertising and recalls. Ben also assists hospitals, clinics, and individual healthcare practitioners comply with a wide range of federal and provincial health-related regulations and policies. Ben has helped clients respond to investigations and complaints by regulators like Health Canada and the College of Physicians and Surgeons of Ontario.
Prior to attending law school, Ben completed a Master of Science degree in Immunology. His research focused on developing new immunosuppression medication for kidney transplant patients.
Experience
- Counsel to Guardian Capital Group Limited in its $1.67 billion go-private transaction with Desjardins Global Asset Management Inc.
- Counsel to Guardian Capital Group Limited in its $1.67 billion go-private transaction with Desjardins Global Asset Management Inc.
